About Conference

First Round of Abstract Submission : September 28, 2019 | Welcome Message

ABOUT CONFERENCE

Cordial welcome from Science Access to participants, from all around the world to attend the 3rd World Congress on Infectious Diseases (Infectious Diseases 2020) during September 14-16, 2020 in Sydney, Australia. The theme of the conference includes “To Safeguard Public health, Novel Research in the Prevention and Treatment of Infectious Diseases”.

Science Access (SA) is initiated to meet a need or to pursue collective goals of the scientific community, especially in exchanging the ideas which facilitate the growth of research and development.

Microorganisms like viruses, bacteria, parasites, and fungi are cause Infectious diseases. The diseases can be spread, directly or indirectly, from one person to another. Zoonotic diseases are infectious diseases of animals that can cause disease when transmitted to humans. Microorganisms that cause disease are collectively called pathogens, which cause disease either by distracting the bodies & stimulating the immune system to produce a protective response, resulting in high inflammation, fever, and other symptoms.

Infectious diseases can be spread from one person to another, for example through contact with bodily fluids, by aerosols (through coughing and sneezing), or via a vector, for example a mosquito. Infectious diseases are one of the leading causes of worldwide deaths.

Infectious Diseases 2020 extends a warm welcome to the eminent speakers, delegates, researchers, and pharmaceutical professionals. It is designed for professionals of Pathology, Parasitology and Bacteriology at universities, research centers, associations and companies who are interested in enhancing their research expertise, exchanging perspectives and exploring new ideas. The conference will include topics on Infectious Diseases.

Scientific highlights:

About Venue:

The only country in the world which is its own continent but is actually an Island. Considered as the 13th largest economy and ninth in terms of highest per capita income, this island country has a better quality of lifestyle, education, health facilities, political rights and economic freedom to offer to its citizens. Being a member of the UN, Commonwealth of Nations, World Trade organization this country has always been able to be on the front page of world’s economy. Similarly this country invests a considerable amount of its annual budget in the fields of science and technologies, economics and finance, health and medicine etc. And this is also a very important reason why there are lots of events, workshops and conferences are going on across the country. These conferences and seminars plays a vital role in the country’s integration by providing a common platform for sharing of knowledge and ideas.

Sydney, capital of New South Wales and one of Australia's largest cities, is best known for its harbour front Sydney Opera House, with a distinctive sail-like design. Massive Darling Harbour and the smaller Circular Quay port are hubs of waterside life, with the arched Harbour Bridge and esteemed Royal Botanic Garden nearby. Sydney Tower’s outdoor platform, the Skywalk, offers 360-degree views of the city and suburbs.

Market analysis:

Infectious Diseases Therapeutic Market

The infectious diseases therapeutic market in US is assessed to grow at a rate of 3.37% between 2014- 2019. As per the records, 25% of expiries are mainly due to infectious diseases worldwide. Modern market development shows that North America has the more global market for infectious diseases therapeutics due to mounting frequency of infectious diseases and due to growth in aging people. Followed by North America highest global advertise is estimated in Asia then followed by the Europe in the global infectious diseases therapeutics market. In Asia-Pacific region, China and India are estimated to be the fastest growing infectious diseases therapeutics advertises. Important reasons behind the highest global market of infectious diseases therapeutics market in the above countries is mainly due to large number of patients and due to increase in organization capital. Some of the primary concerns playing an imperative role in the global infective diseases therapeutics market are Merck & Co., Pfizer, Johnson & Johnson, F. Hoffmann-La Roche, GlaxoSmithKline Pharmaceutical, Inc., Auritec Pharmaceuticals, Novartis, Isis Analgesics and Gilead Skills.

Infectious Diseases Diagnostics Market

Market for infectious disease molecular diagnostics tests includes sanatoriums, blood banks, reference test center. North America has the chief global advertise for molecular diagnostics tests followed by Europe due to the market accessibility of the tests and extraordinary existence rate of various infectious diseases such as HPV, hepatitis and bacterial infections.  

Asia Pacific, Latin America and Middle East are estimated to be the probable markets in the upcoming years. Foremost enterprises which play a crucial role in infectious disease molecular diagnostics investigations market are Abbott Laboratories, Affymetrix, Inc., Becton, Dickinson and Company, bioMérieux, Hologic, Inc., Natural life Technologies, Myriad Genetics, Inc., Qiagen N.V. and others.

Key players in the market:

Abaxis, Inc.

Abbott Laboratories, Inc.

Alere, Inc.

Becton, Dickinson & Company

Bio-Rad Laboratories, Inc.

Danaher Corporation (Beckman Coulter)

MegaCor Diagnostik GmbH

F. Hoffmann-La Roche Ltd.

Trinity Biotech plc

Zoetis, Inc.

On the basis of region, the Infectious Disease Diagnostics Market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). North America accounted for the largest share of the IDD market, followed by Europe. Both markets are estimated to register single-digit growth rates over the next five years.

Major Infectious Disease Associations:

European Society of Clinical Microbiology and Infectious Diseases;The Japanese Association for Infectious Diseases;International Union of Microbiological Societies;Society for General Microbiology;Federation of Infection Societies;Canadian Society of Microbiologists;British Infection Association;Federation of European Microbiological Societies;Welsh Microbiology Association;Clinical Virology Network;Infectious Diseases Society of America;American Society for Microbiology;Society for Applied Microbiology;Association of Medical Microbiology and Infectious Disease;Asia Pacific Foundation for Infectious Diseases;Indian Association of Pathologists and Microbiologists;International Academy of Pathologists

Universities related to Infectious Diseases

University of Cambridge;Kings College of London;London School of Hygiene and Tropical Medicine;Imperial College London;UCL Institute of Epidemiology and Healthcare;University of Sheffield;Pediatric Infectious Diseases Society;Columbia University;University of Maryland;University of Pittsburgh;Emory Health Sciences;Queensland University of Technology;University of Liverpool;University of Colorado Denver;Infectious Diseases Society of America;Medical College of Georgia at Georgia Regents University;Swedish Institute for Infectious Disease Control;Uppsala University;University of Gothenburg;University of Otego;Oslo University

 

pathology@sciaccess.online

infectiousdiseases@scienceaccessconferences.online

infectiousdiseasesconferences@sciaccess.online

 

big-event

MAIL US AT

Subscribe Neurology Conference
 

Authorization Policy: By registering for the conference you grant permission to SCIENCEACCESS to photograph, film or record and use your name, likeness, image, voice and comments and to publish, reproduce, exhibit, distribute, broadcast, edit and/or digitize the resulting images and materials in publications, advertising materials, or in any other form worldwide without compensation. Taking of photographs and/or video recording by participants/others during conference is prohibited without prior approval. Contact us for any queries. Privacy is Everyone's Concern!

 

 

infectiousdiseases@ scienceaccessconferences.onlineinfectiousdiseases@ scienceaccessconferences.onlineinfectiousdiseases@ scienceaccessconferences.online